114 related articles for article (PubMed ID: 12439326)
1. Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease.
Vlieger EJ; Maas M; Akkerman EM; Hollak CE; Den Heeten GJ
J Comput Assist Tomogr; 2002; 26(5):843-8. PubMed ID: 12439326
[TBL] [Abstract][Full Text] [Related]
2. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
Gan C; Robertson PL; Lai JKC; Szer J
Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
[TBL] [Abstract][Full Text] [Related]
4. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
[TBL] [Abstract][Full Text] [Related]
5. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
[TBL] [Abstract][Full Text] [Related]
6. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease.
van Dussen L; Zimran A; Akkerman EM; Aerts JM; Petakov M; Elstein D; Rosenbaum H; Aviezer D; Brill-Almon E; Chertkoff R; Maas M; Hollak CE
Blood Cells Mol Dis; 2013 Mar; 50(3):206-11. PubMed ID: 23199589
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
[TBL] [Abstract][Full Text] [Related]
8. Enhanced vertebra to disk ratio as a new semi-quantitative imaging biomarker for Gaucher disease patients.
Beaumont H; Maas M; Wormanns D; Zaim S; Klifa C; Faye N; Iannessi A
Eur J Radiol; 2020 Aug; 129():109091. PubMed ID: 32497944
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
[TBL] [Abstract][Full Text] [Related]
10. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
[TBL] [Abstract][Full Text] [Related]
11. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease.
Razek AAKA; Abdalla A; Barakat T; El-Taher H; Ali K
Clin Imaging; 2018; 51():318-322. PubMed ID: 29958157
[TBL] [Abstract][Full Text] [Related]
12. Use of IDEAL-IQ in Quantifying Femoral Bone Marrow Involvement in Gaucher Disease.
Hou B; Cidanwangjiu ; Zhang H; Wang F; Qiu Z; Zhang Y; Jin Z
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):637-642. PubMed ID: 37382507
[TBL] [Abstract][Full Text] [Related]
13. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
15. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease.
Roca M; Mota J; Alfonso P; Pocoví M; Giraldo P
Eur J Radiol; 2007 Apr; 62(1):132-7. PubMed ID: 17161930
[TBL] [Abstract][Full Text] [Related]
16. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
Mariani G; Perri M; Minichilli F; Ortori S; Linari S; Giona F; Di Rocco M; Cappellini MD; Guidoccio F; Erba PA
AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.
van Dussen L; Akkerman EM; Hollak CE; Nederveen AJ; Maas M
J Inherit Metab Dis; 2014 Nov; 37(6):1003-11. PubMed ID: 24924293
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of vertebral marrow adipose tissue in postmenopausal female using MRI chemical shift-based water-fat separation.
Li GW; Xu Z; Chen QW; Tian YN; Wang XY; Zhou L; Chang SX
Clin Radiol; 2014 Mar; 69(3):254-62. PubMed ID: 24286935
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far.
Komninaka V; Kolomodi D; Christoulas D; Marinakis T; Papatheodorou A; Repa K; Voskaridou E; Revenas K; Terpos E
Eur J Haematol; 2015 Oct; 95(4):342-51. PubMed ID: 25645321
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between focal malignant marrow-replacing lesions and benign red marrow deposition of the spine with T2*-corrected fat-signal fraction map using a three-echo volume interpolated breath-hold gradient echo Dixon sequence.
Kim YP; Kannengiesser S; Paek MY; Kim S; Chung TS; Yoo YH; Yoon CS; Song HT; Lee YH; Suh JS
Korean J Radiol; 2014; 15(6):781-91. PubMed ID: 25469090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
